Organogenesis Holdings Inc. (ORGO) Q2 FY26 Earnings Call

Q2 revenue fell 58% year over year, while net product revenue rose 18% sequentially.

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-08-06
Length30 minutes
EPS$-0.71
Revenue$43.8M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All ORGO earnings ยท Back to ORGO overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.